Fred Hassan - 14 May 2021 Form 4 Insider Report for Prometheus Biosciences, Inc.

Role
Director
Signature
/s/ Timothy K. Andrews, as attorney-in-fact for Fred Hassan
Issuer symbol
N/A
Transactions as of
14 May 2021
Net transactions value
$0
Form type
4
Filing time
17 May 2021, 19:24:24 UTC
Next filing
26 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXDX Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 14 May 2021 Common Stock 40,000 $16.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on May 14, 2021, subject to the Reporting Person's continued service with the Issuer through each vest date.